Gubareva LV - Search Results

1

Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013-14.

Okomo-Adhiambo M, Fry AM, Su S, Nguyen HT, Elal AA, Negron E, Hand J, Garten RJ, Barnes J, Xiyan X, Villanueva JM, Gubareva LV; 2013–14 US Influenza Antiviral Working Group. Okomo-Adhiambo M, et al. Among authors: gubareva lv. Emerg Infect Dis. 2015 Jan;21(1):136-41. doi: 10.3201/eid2101.141006. Emerg Infect Dis. 2015. PMID: 25532050 Free PMC article.

2

Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir.

Gubareva LV, Kaiser L, Matrosovich MN, Soo-Hoo Y, Hayden FG. Gubareva LV, et al. J Infect Dis. 2001 Feb 15;183(4):523-31. doi: 10.1086/318537. Epub 2001 Jan 11. J Infect Dis. 2001. PMID: 11170976 Clinical Trial.

3

Accumulation of defective neuraminidase (NA) genes by influenza A viruses in the presence of NA inhibitors as a marker of reduced dependence on NA.

Nedyalkova MS, Hayden FG, Webster RG, Gubareva LV. Nedyalkova MS, et al. Among authors: gubareva lv. J Infect Dis. 2002 Mar 1;185(5):591-8. doi: 10.1086/339358. Epub 2002 Feb 14. J Infect Dis. 2002. PMID: 11865415

4

Protection afforded by intranasal immunization with the neuraminidase-lacking mutant of influenza A virus in a ferret model.

Mishin VP, Nedyalkova MS, Hayden FG, Gubareva LV. Mishin VP, et al. Among authors: gubareva lv. Vaccine. 2005 Apr 22;23(22):2922-7. doi: 10.1016/j.vaccine.2004.11.058. Vaccine. 2005. PMID: 15780741

5

Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.

Mishin VP, Novikov D, Hayden FG, Gubareva LV. Mishin VP, et al. Among authors: gubareva lv. J Virol. 2005 Oct;79(19):12416-24. doi: 10.1128/JVI.79.19.12416-12424.2005. J Virol. 2005. PMID: 16160169 Free PMC article.

6

Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors.

Mishin VP, Hayden FG, Gubareva LV. Mishin VP, et al. Among authors: gubareva lv. Antimicrob Agents Chemother. 2005 Nov;49(11):4515-20. doi: 10.1128/AAC.49.11.4515-4520.2005. Antimicrob Agents Chemother. 2005. PMID: 16251290 Free PMC article.

7

Recovery of drug-resistant influenza virus from immunocompromised patients: a case series.

Ison MG, Gubareva LV, Atmar RL, Treanor J, Hayden FG. Ison MG, et al. Among authors: gubareva lv. J Infect Dis. 2006 Mar 15;193(6):760-4. doi: 10.1086/500465. Epub 2006 Feb 13. J Infect Dis. 2006. PMID: 16479508 Review.

8

Comparative activities of oseltamivir and A-322278 in immunocompetent and immunocompromised murine models of influenza virus infection.

Ison MG, Mishin VP, Braciale TJ, Hayden FG, Gubareva LV. Ison MG, et al. Among authors: gubareva lv. J Infect Dis. 2006 Mar 15;193(6):765-72. doi: 10.1086/500464. Epub 2006 Feb 13. J Infect Dis. 2006. PMID: 16479509

9

Evaluation of methyl inosine monophosphate (MIMP) and peramivir activities in a murine model of lethal influenza A virus infection.

Mishin VP, Hayden FG, Signorelli KL, Gubareva LV. Mishin VP, et al. Among authors: gubareva lv. Antiviral Res. 2006 Aug;71(1):64-8. doi: 10.1016/j.antiviral.2006.02.006. Epub 2006 Mar 9. Antiviral Res. 2006. PMID: 16581141

10

Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.

Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y, Shu Y, Gubareva LV, Cox NJ, Klimov AI. Deyde VM, et al. Among authors: gubareva lv. J Infect Dis. 2007 Jul 15;196(2):249-57. doi: 10.1086/518936. Epub 2007 Jun 7. J Infect Dis. 2007. PMID: 17570112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters